Dennis Bastas (#1128)
- $ 4 B
- pharmaceuticals
- Australia
- M
- 59 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Dennis Bastas is chairman and group CEO of Australia-based diversified health and beauty company DBG Health. Bastas was born to Greek parents who migrated to Melbourne in 1960s. He began his career in logistics at retailing giant Coles Myer. In the early 2000s he founded Genepharm Australasia, which he later sold to Watson in 2012 for $252 million. In 2023, Bastas' DBG Health acquired three companies including Arrotex Pharmaceuticals, the country's largest pharmaceutical company by market share, for $671 million. In 2025, Bastas sold a stake in DBG Global Enterprises, the holding company of DBG Health, to global merchant bank BDT & MSD Partners for $1 billion, valuing the company at more than $4.7 billion.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Dennis Bastas’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Dennis Bastas’s net worth journey over the years, highlighting key growth phases and financial milestones.
© Iconic Billionaires